FDA approves first treatment for rare blood disease
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves new treatment for patients with acute myeloid leukemia
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA highlights record-breaking number of generic drug approvals in October
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves new drug to treat influenza
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs
- FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
- FDA approves first treatment for advanced form of the second most common skin cancer
- FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
- FDA approves new kind of treatment for hairy cell leukemia
- FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease
- FDA approves treatment for two rare types of non-Hodgkin lymphoma